Dr. Patrick Dillon, MD
Claim this profileUniversity of Virginia
Studies Breast Cancer
Studies Breast cancer
9 reported clinical trials
18 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
ER negative
2Breast Cancer
Stage IV
HER2 negative
ER negative
Affiliated Hospitals
Clinical Trials Patrick Dillon, MD is currently running
Focused Ultrasound + Gemcitabine
for Breast Cancer
This study will test the use of focused ultrasound ablation, low-dose gemcitabine (a chemotherapy) and the combination of focused ultrasound ablation plus low-dose gemcitabine in patients with early-stage breast cancers. We will be testing the effects of each of these regimens on cells in the immune system. We hypothesize that the combination of focused ultrasound ablation and gemcitabine will decrease myeloid-derived suppressor cells and will increase T cell activity. We also hypothesize that focused ultrasound ablation and low-dose gemcitabine will be safe and will result in non-inferior surgical completion rates and tumor margin assessments.
Recruiting1 award Phase 111 criteria
Dendritic Cell Vaccine + Pembrolizumab
for Brain Metastasis from Breast Cancer
This trial studies a treatment combining a vaccine and a drug to boost the immune system in patients with aggressive breast cancer that has spread to the brain. The vaccine helps the immune system recognize cancer cells, while the drug enhances its ability to fight them.
Recruiting1 award Phase 212 criteria
More about Patrick Dillon, MD
Clinical Trial Related7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Patrick Dillon, MD has experience with
- Pembrolizumab
- Paclitaxel
- Cyclophosphamide
- HER2 BATs
- Focused Ultrasound
- Gemcitabine
Breakdown of trials Patrick Dillon, MD has run
Breast Cancer
Breast cancer
Uterine Tumors
HER2 Negative
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patrick Dillon, MD specialize in?
Patrick Dillon, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Patrick Dillon, MD currently recruiting for clinical trials?
Yes, Patrick Dillon, MD is currently recruiting for 2 clinical trials in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Patrick Dillon, MD has studied deeply?
Yes, Patrick Dillon, MD has studied treatments such as Pembrolizumab, Paclitaxel, Cyclophosphamide.
What is the best way to schedule an appointment with Patrick Dillon, MD?
Apply for one of the trials that Patrick Dillon, MD is conducting.
What is the office address of Patrick Dillon, MD?
The office of Patrick Dillon, MD is located at: University of Virginia, Charlottesville, Virginia 22903 United States. This is the address for their practice at the University of Virginia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.